leiomyosarcoma of the maxilla

Clicks: 196
ID: 200158
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #17 of 19 articles by views in aids care

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Leiomyosarcomas (LMSs) are relatively uncommon mesenchymal neoplasms of smooth muscle differentiation. Only 1% of the lesions occur in the head and neck region. Surgical excision with radiotherapy and chemotherapy is the most commonly executed procedure for recurrent and metastatic tumors. We report a rare LMS case of the maxilla, defined in a 19-year-old male patient. Following the diagnosis of a malignant neoplasm on frozen section, wide resection, with a 1 cm clear margin, was performed. The lesion was then sent for histopathological examination. Spindle cell malignancy was found in histopathological sections of the lesion, histologically consistent with LMS. A radiographical evaluation, magnetic resonance imaging, computerized tomography, and positron emission tomography were performed to detect metastasis. Signs of local recurrence or distant metastasis were not noted at the 12-month follow-up following the definitive surgical procedure.
Reference Key
bayramoglu2018journalleiomyosarcoma Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Zeynep Bayramoglu;Zeynep Gümrükçü
Journal aids care
Year 2018
DOI
10.4103/jorr.jorr_34_17
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.